The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4648-4656

  D'Ambrosi, Nadia ^a   Finocchi, Pamela ^a   Apolloni, Savina ^a   Cozzolino, Mauro ^a   Ferri, Alberto ^a   Padovano, Valeria ^b   Pietrini, Grazia ^b   Carri, Maria Teresa ^a,c   Volonte, Cinzia ^a  

^a CNR   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MESSENGER RNA; PURINERGIC P2 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ALANINE; AUTACOID; COPPER ZINC SUPEROXIDE DISMUTASE; GLYCINE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; CELL VIABILITY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; MICROGLIA; MOUSE; NERVE CELL; NEUROBLASTOMA CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; AMINO ACID SUBSTITUTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL LINE; COCULTURE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE; UPREGULATION;

ALANINE; AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCINE; HUMANS; INFLAMMATION MEDIATORS; MICE; MICE, TRANSGENIC; MICROGLIA; PHENOTYPE; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 70449732762     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901212     Document Type: Article

References (54)

1. Cozzolino, M., A. Ferri, and M. T. Carri. 2008. Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications. Antioxid. Redox. Signal 10: 405-443.
2. Gao, H. M., and J. S. Hong. 2008. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 29: 357-365.
3. Schultzberg, M., C. Lindberg, A. F. Aronsson, E. Hjorth, S. D. Spulber, and M. Oprica. 2007. Inflammation in the nervous system: physiological and pathophysiological aspects. Physiol. Behav. 92: 121-128. (Pubitemid 47381377)
4. Hensley, K., M. Mhatre, S. Mou, Q. N. Pye, C. Stewart, M. West, and K. S. Williamson. 2006. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid. Redox. Signal 8: 2075-2087. (Pubitemid 46489632)
5. Boillee, S., C. Vande Velde, and D. W. Cleveland. 2006. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59. (Pubitemid 44466358)
6. Lino, M. M., C. Schneider, and P. Caroni. 2002. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22: 4825-4832.
7. Pramatarova, A., J. Laganiere, J. Roussel, K. Brisebois, and G. A. Rouleau. 2001. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21: 3369-3374. (Pubitemid 32422802)
8. Boillee, S., K. Yamanaka, C. S. Lobsiger, N. G. Copeland, N. A. Jenkins, G. Kassiotis, G. Kollias, and D. W. Cleveland. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392. (Pubitemid 43839552)
9. Hanisch, U. K., and H. Kettenmann. 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10: 1387-1394.
10. Inoue, K. 2006. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol. Ther. 109: 210-226. (Pubitemid 41740822)
11. 12 receptors in ATP-induced microglial chemotaxis. Glia 55: 604-616.
12. 6 receptors is a mediator of microglial phagocytosis. Nature 446: 1091-1095.
13. 2+ mobilization and COX-2 in human microglia. Glia 43: 95-103.
14. 7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278: 13309-13317.
15. 7 receptor in Alzheimer disease and amyloid-β peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol. 65: 1090-1097.
16. Tsuda, M., Y. Shigemoto-Mogami, S. Koizumi, A. Mizokoshi, S. Kohsaka, M. W. Salter, and K. Inoue. 2003. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424: 778-783. (Pubitemid 37021707)
17. 12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J. Neurosci. 28: 2892-2902.
18. 12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9: 1512-1519.
19. Avignone, E., L. Ulmann, F. Levavasseur, F. Rassendren, and E. Audinat. 2008. Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J. Neurosci. 28: 9133-9144.
20. 7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 6: 12.
21. 4 purinergic receptor-like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis. J. Comp. Neurol. 506: 75-92.
22. Andries, M., P. Van Damme, W. Robberecht, and L. Van Den Bosch. 2007. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 25: 8-16. (Pubitemid 44765212)
23. Righi, M., A. Pierani, A. Boglia, G. De Libero, L. Mori, V. Marini, and P. Ricciardi-Castagnoli. 1989. Generation of new oncogenic murine retroviruses by cotransfection of cloned AKR and MH2 proviruses. Oncogene 4: 223-230. (Pubitemid 19096947)
24. Giulian, D., and T. J. Baker. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6: 2163-2178. (Pubitemid 16043659)
25. Ferri, A., M. Cozzolino, C. Crosio, M. Nencini, A. Casciati, E. B. Gralla, G. Rotilio, J. S. Valentine, and M. T. Carri. 2006. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc. Natl. Acad. Sci. USA 103: 13860-13865. (Pubitemid 44413998)
26. Ferri, A., M. Nencini, A. Casciati, M. Cozzolino, D. F. Angelini, P. Longone, A. Spalloni, G. Rotilio, and M. T. Carri. 2004. Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells. FASEB J. 18: 1261-1263. (Pubitemid 39561570)
27. Amadio, S., N. D'Ambrosi, F. Cavaliere, B. Murra, G. Sancesario, G. Bernardi, G. Burnstock, and C. Volonte. 2002. P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 42: 489-501. (Pubitemid 34304242)
28. Farber, K., S. Markworth, U. Pannasch, C. Nolte, V. Prinz, G. Kronenberg, K. Gertz, M. Endres, I. Bechmann, K. Enjyoji, et al. 2008. The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia 56: 331-341.
29. Moller, T., O. Kann, A. Verkhratsky, and H. Kettenmann. 2000. Activation of mouse microglial cells affects P2 receptor signaling. Brain Res. 853: 49-59. (Pubitemid 30015998)
30. 2+ mobilization and functional responses in microglia: effects of low levels of ATP. J. Neurosci. Res. 81: 349-356.
31. Ferrari, D., P. Chiozzi, S. Falzoni, M. Dal Susino, G. Collo, G. Buell, and F. Di Virgilio. 1997. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36: 1295-1301.
32. Hide, I., M. Tanaka, A. Inoue, K. Nakajima, S. Kohsaka, K. Inoue, and Y. Nakata. 2000. Extracellular ATP triggers tumor necrosis factor-α release from rat microglia. J. Neurochem. 75: 965-972. (Pubitemid 30660484)
33. 7 and the inflammasome. Trends Pharmacol. Sci. 28: 465-472.
34. 7 receptor modulation of β-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia. J. Neuroimmunol. 147: 56-61.
35. Beers, D. R., J. S. Henkel, Q. Xiao, W. Zhao, J. Wang, A. A. Yen, L. Siklos, S. R. McKercher, and S. H. Appel. 2006. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 103: 16021-16026.
36. Davalos, D., J. Grutzendler, G. Yang, J. V. Kim, Y. Zuo, S. Jung, D. R. Littman, M. L. Dustin, and W. B. Gan. 2005. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8: 752-758. (Pubitemid 43085841)
37. Farber, K., and H. Kettenmann. 2006. Purinergic signaling and microglia. Pflugers Arch. 452: 615-621.
38. 4 receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 56: 50-58.
39. 4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 28: 11263-11268.
40. 7 nucleotide receptor in a mouse microglial cell line. FEBS Lett. 581: 3019-3026.
41. Volonte, C., and N. D'Ambrosi. 2009. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. FEBS J. 276: 318-329.
42. Braun, N., J. Sevigny, S. C. Robson, K. Enjyoji, O. Guckelberger, K. Hammer, F. Di Virgilio, and H. Zimmermann. 2000. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur. J. Neurosci. 12: 4357-4366. (Pubitemid 32037844)
43. Yoshihara, T., S. Ishigaki, M. Yamamoto, Y. Liang, J. Niwa, H. Takeuchi, M. Doyu, and G. Sobue. 2002. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80: 158-167. (Pubitemid 34614588)
44. 2 a pathogenic factor in amyotrophic lateral sclerosis? Ann. Neurol. 59: 980-983.
45. Hensley, K., R. A. Floyd, B. Gordon, S. Mou, Q. N. Pye, C. Stewart, M. West, and K. Williamson. 2002. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J. Neurochem. 82: 365-374. (Pubitemid 34774627)
46. Almer, G., C. Guegan, P. Teismann, A. Naini, G. Rosoklija, A. P. Hays, C. Chen, and S. Przedborski. 2001. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann. Neurol. 49: 176-185. (Pubitemid 32157993)
47. 7 receptor. FEBS Lett. 439: 26-30.
48. 7 receptors. Mol. Pharmacol. 58: 82-88.
49. Bal-Price, A., and G. C. Brown. 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21: 6480-6491. (Pubitemid 32781092)
50. Ferri, A., M. Nencini, M. Cozzolino, P. Carrara, S. Moreno, and M. T. Carri. 2008. Inflammatory cytokines increase mitochondrial damage in motoneuronal cells expressing mutant SOD1. Neurobiol. Dis. 32: 454-460.
51. Gowing, G., F. Dequen, G. Soucy, and J. P. Julien. 2006. Absence of tumor necrosis factor-α does not affect motor neuron disease caused by superoxide dismutase 1 mutations. J. Neurosci. 26: 11397-11402. (Pubitemid 44772169)
52. Apolloni, S., C. Montilli, P. Finocchi, and S. Amadio. 2009. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events. FEBS J. 276: 354-364.
53. Ferrari, D., P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio. 1997. Purinergic modulation of interleukin-1 β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185: 579-582. (Pubitemid 27078376)
54. Guthrie, P. B., J. Knappenberger, M. Segal, M. V. Bennett, A. C. Charles, and S. B. Kater. 1999. ATP released from astrocytes mediates glial calcium waves. J. Neurosci. 19: 520-528.